The presence of background infection in HU-treated cells with high titer virus challenge (Fig. 6a and b; Fig. S1c), despite using higher inhibitor concentrations, could be attributed to the more pronounced inhibition of RRM2, but not RRM2B, by HU (36, 37). The gene discussed is RRM2B; the disease is infection.